Who are Valfixmed's investors?

Valfixmed's investors include BayMed Venture Partners.

How much funding has Valfixmed raised?

Valfixmed has disclosed $1.1M raised across 1 round.

Where is Valfixmed headquartered?

Valfixmed is headquartered in Tel Aviv-Yafo.

Valfixmed

Tel Aviv-Yafo · Founded 2019 · 1 known investors

Find your way into Valfixmed

Paths you didn't know you had: your email and LinkedIn already hold routes to the Valfixmed team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure. The technology targets patients with mitral valve disease and heart failure.

Biotech Healthtech Medical Devices Robotics

Founders & leadership

Philip LavinNamed on SEC filing

Elad YaacobyNamed on SEC filing

Eli BarNamed on SEC filing

Board

Gary Gershony Board directorFounding General Partner at BayMed Venture Partners

Investors · 1

BayMed Venture Partnerslisted by BayMed Venture PartnersSan Francisco

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 1 round · 2018

▶$1.1MraisedOct 2019 · 12 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Philip LavinDirector
Elad YaacobyDirector
Eli BarExecutive Officer, Director
Gary GershonyDirector

Offering amount: $1.7M
Amount sold: $1.1M
Minimum investment: $10K
First sale: Aug 2018
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Valfixmed do?: VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure. The technology targets patients with mitral valve disease and heart failure.
Who are Valfixmed's investors?: Valfixmed's investors include BayMed Venture Partners.
How much funding has Valfixmed raised?: Valfixmed has disclosed $1.1M raised across 1 round.
Where is Valfixmed headquartered?: Valfixmed is headquartered in Tel Aviv-Yafo.